Libra Infusions Limited announcements
229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (19).
- Trading of the shares of the company will resume on 27.12.2023.
Trading of the shares of the company will resume on 27.12.2023.
- Trading of the shares of the company will remain suspended on record date i.e., 26.12.2023.
Trading of the shares of the company will remain suspended on record date i.e., 26.12.2023.
- Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 21.12.2023 to 24.12.2023 and trading of the shares will remain suspended on record date i.e., 26.12.2023 for entitlement of 50\% Stock Dividend.
- Refer to the earlier news disseminated on 12.12.2023 regarding change of AGM date, the Company has again informed that d
Refer to the earlier news disseminated on 12.12.2023 regarding change of AGM date, the Company has again informed that due to unavoidable circumstances the AGM of the Company will be held on December 27, 2023 at 11:00 AM instead of earlier declared date December 21, 2023. Other information of the AGM will remain unchanged.
- Refer to their earlier news disseminated by DSE on 12.11.2023 regarding record date for entitlement of stock dividend, t
Refer to their earlier news disseminated by DSE on 12.11.2023 regarding record date for entitlement of stock dividend, the Company has further informed that BSEC has accorded its consent for their declaration of 50\% Stock Dividend for the year ended June 30, 2021. The record date for entitlement of the Stock Dividend will be on December 26, 2023.
- Refer to the earlier news of the company disseminated on 28.11.2023 regarding reschedule date of the AGM, the Company ha
Refer to the earlier news of the company disseminated on 28.11.2023 regarding reschedule date of the AGM, the Company has further informed that, due to unavoidable circumstances, the AGM of the Company will be held on December 21, 2023 at 11:00 AM instead of earlier declared date December 14, 2023.
- In response to the DSE query dated December 05, 2023, the company has informed that there is no undisclosed price sensit
In response to the DSE query dated December 05, 2023, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.
- The Company has further informed that due to unavoidable circumstances, the AGM will be held on December 14, 2023 at 11:
The Company has further informed that due to unavoidable circumstances, the AGM will be held on December 14, 2023 at 11:00 AM instead of earlier declared date November 30, 2023 at 11:00 AM. Other information will remain unchanged.
- Resumption after Record date
Trading of the shares of the company will resume on 13.11.2023.
- Regarding record date for entitlement of 50% stock dividend
Refer to the earlier news disseminated by DSE on 22.10.2023 regarding dividend declaration for the year ended June 30, 2021, the Company has further informed that it has not got approval from BSEC yet for issuance of 50% Stock Dividend for the year ended June 30, 2021. The record date (12.11.2023) is only applicable for entitlement of 30% cash dividend. The company has also informed that it will declare record date for stock dividend after getting approval from BSEC.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 12.11.2023.
- The company has announced their expansion of largest Brand New Dialysis Fluid Production Plant in the Country. The Board
The company has announced their expansion of largest Brand New Dialysis Fluid Production Plant in the Country. The Board of Directors of the Company decided the largest Dialysis Fluid Production is going to start from late December 2023. All the permission from Regulatory Affairs body sought. The company has already imported brand new Machinery from China for the Plant. (cont.)
- Expansion of largest Brand New Dialysis Fluid Production Plant
(Cont. news of LIBRAINFU): All Civil, Electricals and HVAC constructions have already been completed for going into large Production. The company has also informed that it will not only cater local demand and will also export large quantity of Dialysis Fluid productions for export purposes from this unit. (end)
The first part of this announcement is missing from the archive. - Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 08.11.2023 to 09.11.2023 and trading of the shares will remain suspended on record date i.e., 12.11.2023.
- Dividend Declaration
The Board of Directors has recommended 30% Cash only for General Shareholders and 50% Stock dividend for the year ended June 30, 2021. The Stock Dividend is subject to the approval of BSEC. Date of AGM: 30.11.2023. Time: 11:00 AM, Venue: Digital Platform. Record Date: 12.11.2023. The Company has also reported EPS of Tk. 0.15, NAV per share of Tk. 1,261.00 and NOCFPS of Tk. 2.46 for the year ended June 30, 2021 as against Tk. (7.78), Tk. 1,261.00 and Tk. (0.14) respectively for the year ended June 30, 2020.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (22.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Dividend Declaration (Additional Information)
The company has further informed that the reason for declaring the Stock dividend is to increase the paid-up capital to BDT 30.00 crore. The company has also informed that Sponsors and Directors hold 516,960 shares, general shareholders hold 984,960 shares of the company, and the general shareholders will get cash dividend of BDT 29,54,880/-. Reasons for deviation in EPS: EPS has been increased due to increase in sales and other income.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 19, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2021.
- Query Response
In response to a DSE query dated October 04, 2023, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.